Cullinan Therapeutics (CGEM) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.99
-0.89
-0.79
-0.69

Details

Expected EPS
-0.749582
Actual EPS
-0.73
Surprise EPS
0.02
Surprise Percent
+2.61%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.73 per share for Q1 2025.

0 Comments

Share your thoughts